179 related articles for article (PubMed ID: 25131963)
1. Multi-modality management for loco-regionally advanced laryngeal and hypopharyngeal cancer: balancing the benefit of efficacy and functional preservation.
Qian W; Zhu G; Wang Y; Wang X; Ji Q; Wang Y; Dou S
Med Oncol; 2014 Sep; 31(9):178. PubMed ID: 25131963
[TBL] [Abstract][Full Text] [Related]
2. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
Varghese BT; Sebastian P; Mathew A
Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
[TBL] [Abstract][Full Text] [Related]
4. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.
Posner MR; Norris CM; Wirth LJ; Shin DM; Cullen KJ; Winquist EW; Blajman CR; Mickiewicz EA; Frenette GP; Plinar LF; Cohen RB; Steinbrenner LM; Freue JM; Gorbunova VA; Tjulandin SA; Raez LE; Adkins DR; Tishler RB; Roessner MR; Haddad RI;
Ann Oncol; 2009 May; 20(5):921-7. PubMed ID: 19179556
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nodal metastasis in advanced tumors of the larynx and hypopharynx.
Barroso Ribeiro R; Ribeiro Breda E; Fernandes Monteiro E
Acta Otorrinolaringol Esp; 2012; 63(4):292-8. PubMed ID: 22579383
[TBL] [Abstract][Full Text] [Related]
6. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers.
Nair SV; Mair M; Sawarkar N; Chakrabarti S; Qayyumi B; Nair D; Chaturvedi P; Gupta T; Agrawal JP
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2311-2316. PubMed ID: 29959566
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
[TBL] [Abstract][Full Text] [Related]
9. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma.
Zhang M; Gao XS; Qin Y; Sun Y; Ma MW
Chin Med J (Engl); 2019 Nov; 132(22):2698-2704. PubMed ID: 31765356
[TBL] [Abstract][Full Text] [Related]
10. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
[TBL] [Abstract][Full Text] [Related]
11. Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
Lefebvre JL; Ang KK;
Head Neck; 2009 Apr; 31(4):429-41. PubMed ID: 19283793
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
[No Abstract] [Full Text] [Related]
13. HPV: a factor in organ preservation for locally advanced larynx and hypopharynx cancer?
Shaughnessy JN; Farghaly H; Wilson L; Redman R; Potts K; Bumpous J; Silverman C; Dunlap NE
Am J Otolaryngol; 2014; 35(1):19-24. PubMed ID: 24119488
[TBL] [Abstract][Full Text] [Related]
14. Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer.
Tennant PA; Cash E; Bumpous JM; Potts KL
Head Neck; 2014 Nov; 36(11):1628-33. PubMed ID: 24115178
[TBL] [Abstract][Full Text] [Related]
15. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
16. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
[TBL] [Abstract][Full Text] [Related]
17. [Treatment and prognosis of 264 patients with hypopharyngeal carcinoma].
Xu W; Lyu ZH; Sa N; Ma JK; Tian JJ; Feng SH; Cui P; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):346-351. PubMed ID: 29764015
[No Abstract] [Full Text] [Related]
18. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
19. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.
Imanishi Y; Ozawa H; Sakamoto K; Fujii R; Shigetomi S; Habu N; Otsuka K; Sato Y; Watanabe Y; Sekimizu M; Ito F; Tomita T; Ogawa K
BMC Cancer; 2017 Jun; 17(1):445. PubMed ID: 28651556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
